What is the evidence for mortality for the case management approach for a low risk HF population?
The evidence for mortality was of very low quality and did not demonstrate a clear effect with the confidence interval ranging from a decrease and increase in all-cause mortality. One study (n=149) reported two medication outcomes: prescribed ACE- inhibitors at target dose and prescribed beta-blocker at target dose, both of which were of very low quality. The former outcome showed clinical harm for case management while the latter showed no difference. The second study (n=190) also reported a few other outcomes such as hospitalisations, which was of very low quality showing clinical harm for case management.